In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 23rd, 2008 | 32 | Yes |
Popular Name: 4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide 4-(4-(3-(Pyridin-2-yl)-1H-pyrazo…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 452342-67-5 , [452342-67-5]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.74 | 8.04 | -17.99 | 2 | 7 | 0 | 93 | 425.492 | 5 | ↓ |
Ref Reference (pH 7) | 2.74 | 8.04 | -14.3 | 2 | 7 | 0 | 93 | 425.492 | 5 | ↓ |
Lo Low (pH 4.5-6) | 2.74 | 8.24 | -41.61 | 3 | 7 | 1 | 94 | 426.5 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | TGF-beta/Smad | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 7280 | 0.22 | Binding ≤ 10μM |
TGFB1-1-E | Transforming Growth Factor Beta-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 446 | 0.28 | Binding ≤ 10μM |
TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 18 | 0.34 | Binding ≤ 10μM |
Z81020-4-O | HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other | Other | 93 | 0.31 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 18 | 0.34 | Binding ≤ 1μM |
TGFB1_HUMAN | P01137 | Transforming Growth Factor Beta-1, Human | 446 | 0.28 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 7280 | 0.22 | Binding ≤ 10μM |
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 18 | 0.34 | Binding ≤ 10μM |
TGFB1_HUMAN | P01137 | Transforming Growth Factor Beta-1, Human | 446 | 0.28 | Binding ≤ 10μM |
Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 93 | 0.31 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
CDO in myogenesis | |
Downregulation of TGF-beta receptor signaling | |
DSCAM interactions | |
ECM proteoglycans | |
ERK/MAPK targets | |
Influenza Virus Induced Apoptosis | |
KSRP destabilizes mRNA | |
Molecules associated with elastic fibres | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
Platelet degranulation | |
Platelet sensitization by LDL | |
SMAD2/3 MH2 Domain Mutants in Cancer | |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
Syndecan interactions | |
TGF-beta receptor signaling activates SMADs | |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
TGFBR1 KD Mutants in Cancer | |
TGFBR1 LBD Mutants in Cancer | |
TGFBR2 Kinase Domain Mutants in Cancer | |
TGFBR2 MSI Frameshift Mutants in Cancer | |
Transcriptional regulation of white adipocyte differentiation | |
VEGFA-VEGFR2 Pathway |
No pre-computed analogs available. Try a structural similarity search.